Median Diagnostics Inc. (XKON:233250)

Market Cap	25.29B
Revenue (ttm)	7.86B
Net Income (ttm)	-567.58M
Shares Out	1.75M
EPS (ttm)	-496.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2
Average Volume	20
Open	14,000
Previous Close	14,000
Day's Range	14,000 - 14,500
52-Week Range	8,600 - 18,500
Beta	0.26
RSI	45.27
Earnings Date	n/a

About Median Diagnostics

Median Diagnostics Inc. develops, produces, and sells diagnostic methods and kits for early diagnosis and constant monitoring of infectious diseases outbreak in animals. Its products include ELISA for pigs, ruminants, avians, and horses; rapid kits for pigs, ruminants, poultry, canine, feline, erwinia amylovora, and bovine pregnancy; PCR sets for pigs, ruminants, poultry, equine, canine and feline, and shrimps; standard reagents, including AGID, HI, and FA; antigen/antibody, including antibodies for veterinary diagnostics, and antibodies and an...

• Industry: In Vitro and In Vivo Diagnostic Substances
• Founded: 1999
• Country: South Korea
• Stock Exchange: Korea New Exchange
• Ticker Symbol: 233250